GeneFerm Biotechnology Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GeneFerm Biotechnology Co Ltd

Watchlist Manager

Watchlist

Price: 29 TWD -1.69% Market Closed

Market Cap: NT$1.2B

G	GeneFerm Biotechnology Co Ltd TPEX:1796	TW
P	Peregrine Industries Inc OTC:PGID	US
E	Easun Capital Markets Ltd BSE:542906	IN
E	EKF Diagnostics Holdings PLC XBER:LYF	UK
H	Hardwoods Distribution Inc OTC:HDIUF	CA
	Decade Resources Ltd OTC:DECXF	CA
S	Singapore Exchange Ltd XMUN:SOU	SG
W	Walton Advanced Engineering Inc TWSE:8110	TW
C	Clean Seas Seafood Ltd F:C7S	AU

Profitability Summary

GeneFerm Biotechnology Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

27%

Sustainable 3Y Average Gross Margin

27%

Declining Gross Margin

36% > 27%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

19% > 5%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

16% > 2%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.